Patent 7399744 was granted and assigned to Amylin Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.
Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.